Posted by Michael Wonder on 02 Dec 2021
TGA provisional approval of Roche COVID-19 treatment, tocilizumab (Actemra)
1 December 2021 - On 1 December 2021, the TGA granted provisional approval to Roche for the use of tocilizumab (Actemra) for the treatment of COVID-19.
This is the fourth COVID-19 treatment to receive regulatory approval in Australia.
